000 01505 a2200421 4500
005 20250514020708.0
264 0 _c20020109
008 200201s 0 0 eng d
022 _a1076-5174
024 7 _a10.1002/jms.218
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRibeiro, W
245 0 0 _aDetermination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectrometry using tri-deuterated RSD921 as internal standard: application to a phase I clinical trial.
_h[electronic resource]
260 _bJournal of mass spectrometry : JMS
_cOct 2001
300 _a1133-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnesthetics, Local
_xblood
650 0 4 _aAnti-Arrhythmia Agents
_xblood
650 0 4 _aCalibration
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aDeuterium
650 0 4 _aHumans
650 0 4 _aIndicators and Reagents
650 0 4 _aMass Spectrometry
650 0 4 _aPyrroles
_xblood
650 0 4 _aQuality Control
650 0 4 _aReference Standards
650 0 4 _aThiophenes
_xblood
700 1 _aIfa, D R
700 1 _aCorso, G
700 1 _aSalmon, J
700 1 _aMoraes, L A
700 1 _aEberlin, M N
700 1 _ade Nucci, G
773 0 _tJournal of mass spectrometry : JMS
_gvol. 36
_gno. 10
_gp. 1133-9
856 4 0 _uhttps://doi.org/10.1002/jms.218
_zAvailable from publisher's website
999 _c11660013
_d11660013